Form 4: CareDx Director Sells Shares
Insider Transaction (Form 4)
Hannah Valantine, a Director of CareDx, Inc., sold 28,779 shares of common stock on July 16, 2026.
Summary
- Option exercise/conversion: acquired 7,606 Common Stock at $20.56 ($156,379) on July 16, 2026; holds 44,292 after (Direct).
- Option exercise/conversion: acquired 16,048 Common Stock at $14.19 ($227,721) on July 16, 2026; holds 60,340 after (Direct).
- Option exercise/conversion: acquired 5,125 Common Stock at $7.96 ($40,795) on July 16, 2026; holds 65,465 after (Direct).
- Open-market sale: disposed of 28,679 Common Stock at $36.14 ($1,036,588) on July 16, 2026; holds 36,786 after (Direct).
- Open-market sale: disposed of 100 Common Stock at $36.55 ($3,655) on July 16, 2026; holds 36,686 after (Direct).
- Option exercise/conversion: disposed of 7,606 Stock Option (Right to Buy) on July 16, 2026 (Direct).
- Option exercise/conversion: disposed of 16,048 Stock Option (Right to Buy) on July 16, 2026 (Direct).
- Option exercise/conversion: disposed of 5,125 Stock Option (Right to Buy) on July 16, 2026; holds 24,011 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $1,040,243 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Hannah Valantine — Director
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-16 | Option exercise/conversion | Common Stock | 7,606 | $21 | $156.4K | 44,292 |
| 2026-07-16 | Option exercise/conversion | Common Stock | 16,048 | $14 | $227.7K | 60,340 |
| 2026-07-16 | Option exercise/conversion | Common Stock | 5,125 | $8 | $40.8K | 65,465 |
| 2026-07-16 | Open-market sale | Common Stock | 28,679 | $36 | $1.0M | 36,786 |
| 2026-07-16 | Open-market sale | Common Stock | 100 | $37 | $3.7K | 36,686 |
| 2026-07-16 | Option exercise/conversion | Stock Option (Right to Buy) | 7,606 | — | — | 0 |
| 2026-07-16 | Option exercise/conversion | Stock Option (Right to Buy) | 16,048 | — | — | 0 |
| 2026-07-16 | Option exercise/conversion | Stock Option (Right to Buy) | 5,125 | — | — | 24,011 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-16 | Option exercise/conversion (7,606 shares) |
| 2026-07-16 | Option exercise/conversion (16,048 shares) |
| 2026-07-16 | Option exercise/conversion (5,125 shares) |
| 2026-07-16 | Open-market sale (28,679 shares) |
| 2026-07-16 | Open-market sale (100 shares) |
| 2026-07-16 | Option exercise/conversion (7,606 shares) |
| 2026-07-16 | Option exercise/conversion (16,048 shares) |
| 2026-07-16 | Option exercise/conversion (5,125 shares) |
Keywords
insider transaction, Form 4, CDNA, CareDx, Inc., bearish, Hannah Valantine
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.